Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
Survivin is expressed in prostate cancer (PCa), and its downregulation sensitizes PCa cells to chemotherapeutic agents in vitro and in vivo. Small membrane-bound vesicles called exosomes, secreted from the endosomal membrane compartment, contain RNA and protein that they readily transport via exosom...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3473028?pdf=render |
| _version_ | 1819011102211571712 |
|---|---|
| author | Salma Khan Jessica M S Jutzy Malyn May A Valenzuela David Turay Jonathan R Aspe Arjun Ashok Saied Mirshahidi Dan Mercola Michael B Lilly Nathan R Wall |
| author_facet | Salma Khan Jessica M S Jutzy Malyn May A Valenzuela David Turay Jonathan R Aspe Arjun Ashok Saied Mirshahidi Dan Mercola Michael B Lilly Nathan R Wall |
| author_sort | Salma Khan |
| collection | DOAJ |
| description | Survivin is expressed in prostate cancer (PCa), and its downregulation sensitizes PCa cells to chemotherapeutic agents in vitro and in vivo. Small membrane-bound vesicles called exosomes, secreted from the endosomal membrane compartment, contain RNA and protein that they readily transport via exosome internalization into recipient cells. Recent progress has shown that tumor-derived exosomes play multiple roles in tumor growth and metastasis and may produce these functions via immune escape, tumor invasion and angiogenesis. Furthermore, exosome analysis may provide novel biomarkers to diagnose or monitor PCa treatment.Exosomes were purified from the plasma and serum from 39 PCa patients, 20 BPH patients, 8 prostate cancer recurrent and 16 healthy controls using ultracentrifugation and their quantities and qualities were quantified and visualized from both the plasma and the purified exosomes using ELISA and Western blotting, respectively.Survivin was significantly increased in the tumor-derived samples, compared to those from BPH and controls with virtually no difference in the quantity of Survivin detected in exosomes collected from newly diagnosed patients exhibiting low (six) or high (nine) Gleason scores. Exosome Survivin levels were also higher in patients that had relapsed on chemotherapy compared to controls.These studies demonstrate that Survivin exists in plasma exosomes from both normal, BPH and PCa subjects. The relative amounts of exosomal Survivin in PCa plasma was significantly higher than in those with pre-inflammatory BPH and control plasma. This differential expression of exosomal Survivin was seen with both newly diagnosed and advanced PCa subjects with high or low-grade cancers. Analysis of plasma exosomal Survivin levels may offer a convenient tool for diagnosing or monitoring PCa and may, as it is elevated in low as well as high Gleason scored samples, be used for early detection. |
| first_indexed | 2024-12-21T01:22:49Z |
| format | Article |
| id | doaj.art-40116a345e2c4f1f863f2101d3667b89 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T01:22:49Z |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-40116a345e2c4f1f863f2101d3667b892022-12-21T19:20:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01710e4673710.1371/journal.pone.0046737Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.Salma KhanJessica M S JutzyMalyn May A ValenzuelaDavid TurayJonathan R AspeArjun AshokSaied MirshahidiDan MercolaMichael B LillyNathan R WallSurvivin is expressed in prostate cancer (PCa), and its downregulation sensitizes PCa cells to chemotherapeutic agents in vitro and in vivo. Small membrane-bound vesicles called exosomes, secreted from the endosomal membrane compartment, contain RNA and protein that they readily transport via exosome internalization into recipient cells. Recent progress has shown that tumor-derived exosomes play multiple roles in tumor growth and metastasis and may produce these functions via immune escape, tumor invasion and angiogenesis. Furthermore, exosome analysis may provide novel biomarkers to diagnose or monitor PCa treatment.Exosomes were purified from the plasma and serum from 39 PCa patients, 20 BPH patients, 8 prostate cancer recurrent and 16 healthy controls using ultracentrifugation and their quantities and qualities were quantified and visualized from both the plasma and the purified exosomes using ELISA and Western blotting, respectively.Survivin was significantly increased in the tumor-derived samples, compared to those from BPH and controls with virtually no difference in the quantity of Survivin detected in exosomes collected from newly diagnosed patients exhibiting low (six) or high (nine) Gleason scores. Exosome Survivin levels were also higher in patients that had relapsed on chemotherapy compared to controls.These studies demonstrate that Survivin exists in plasma exosomes from both normal, BPH and PCa subjects. The relative amounts of exosomal Survivin in PCa plasma was significantly higher than in those with pre-inflammatory BPH and control plasma. This differential expression of exosomal Survivin was seen with both newly diagnosed and advanced PCa subjects with high or low-grade cancers. Analysis of plasma exosomal Survivin levels may offer a convenient tool for diagnosing or monitoring PCa and may, as it is elevated in low as well as high Gleason scored samples, be used for early detection.http://europepmc.org/articles/PMC3473028?pdf=render |
| spellingShingle | Salma Khan Jessica M S Jutzy Malyn May A Valenzuela David Turay Jonathan R Aspe Arjun Ashok Saied Mirshahidi Dan Mercola Michael B Lilly Nathan R Wall Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS ONE |
| title | Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. |
| title_full | Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. |
| title_fullStr | Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. |
| title_full_unstemmed | Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. |
| title_short | Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. |
| title_sort | plasma derived exosomal survivin a plausible biomarker for early detection of prostate cancer |
| url | http://europepmc.org/articles/PMC3473028?pdf=render |
| work_keys_str_mv | AT salmakhan plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer AT jessicamsjutzy plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer AT malynmayavalenzuela plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer AT davidturay plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer AT jonathanraspe plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer AT arjunashok plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer AT saiedmirshahidi plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer AT danmercola plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer AT michaelblilly plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer AT nathanrwall plasmaderivedexosomalsurvivinaplausiblebiomarkerforearlydetectionofprostatecancer |